A two-part virtual event to help clinical diagnostic labs learn how to improve your existing pipelines for somatic NGS analysis, interpretation and reporting
Speakers:
Laura Lahtinen, PhD
Molecular Biologist, Hospital Nova of Central Finland
Christoph Schmitt
Biologist, GenoPath Diagnostics
Miguel Angel Molina, PhD
Laboratory Scientific Director, PanOncology
Elif Dagdan, PhD
Ruhr University Bochum, RUB Department of General Internal Medicine
Speakers:
Elizabeth Forrester, PhD, MB (ASCP)
Founder and Technical Director at Athena Esoterix
Sarah Murray, PhD, FACMG
Director, Medical Genetics and Genomics, UCSD Center for Advanced Laboratory Medicine
Kristen Champion, PhD, FACMG
Scientific Director, Molecular Oncology at Quest Diagnostics
Martina Lefterova, MD, PhD
Vice President and Clinical Laboratory Director at Guardant
Learn about QIAGEN’s solution for cloud-based NGS secondary analysis and how to get started quickly with configurable pre-made workflows.
Speaker: Leif Schauser, PhD, Director, Global Product Management, QIAGEN Digital Insights
Learn how QIAGEN's high-quality, deeply curated knowledge can help support and scale your variant interpretation. In addition, this talk will discuss the effects of co-occurring variants on prognosis and diagnosis and how to dentify evidence-based therapy options for cancer patients for whom there is no on-label therapy.
Speaker: Kathryn Bungartz, PhD, Professional Clinical Solutions Manager, QIAGEN Digital Insights
Learn how to use the Human Somatic Mutation Database (HSMD) as a clinical validation tool for clinical variant interpretation. In addition, this talk will show you how HSMD helps you gain genetic insights into specific cancer types and stay up-to-date with the latest treatment and clinical trial options.
Speaker: Iman Bhattacharya, Senior Global Product Marketing Manager, QIAGEN Digital Insights
Learn about QIAGEN’s solution for cloud-based NGS secondary analysis and how to get started quickly with configurable pre-made workflows.
Speaker: Neha Jalan, PhD, Professional Services Solution Manager, QIAGEN Digital Insights
Learn how QIAGEN's high-quality, deeply curated knowledge can help support and scale your variant interpretation. In addition, this talk will discuss the effects of co-occurring variants on prognosis and diagnosis and how to dentify evidence-based therapy options for cancer patients for whom there is no on-label therapy.
Speaker: Sheryl Elkin, PhD, Chief Scientific Officer, QIAGEN Digital Insights
Learn how to use the Human Somatic Mutation Database (HSMD) as a clinical validation tool for clinical variant interpretation. In addition, this talk will show you how HSMD helps you gain genetic insights into specific cancer types and stay up-to-date with the latest treatment and clinical trial options.
Speaker: Uma Thirumurthi, PhD, Associate Director of Global Product Management, QIAGEN Digital Insights
Cloud-based service for NGS secondary analysis (FASTQ to VCF)
Clinical decision support for variant interpretation and reporting (VCF to report)
Somatic database to better understand precise variant function and actionability
